SCHEMBL28630073

SCHEMBL28630073

CC(C)N(C(C)C)C(CC#N)OP=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28380914 0.74 SMPD1 (0.30)
SCHEMBL22367664 0.74
SCHEMBL7906814 0.72
SCHEMBL6854956 0.69
SCHEMBL442365 0.67
SCHEMBL7743643 0.66 TSHR (0.32)
SCHEMBL7454401 0.65 TSHR (0.35)
SCHEMBL10495860 0.61
SCHEMBL8191870 0.61 TSHR (0.32)
SCHEMBL27294287 0.61 TSHR (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118234862-A Modified short interfering nucleic acid molecules (siNA) and uses thereof 阿利戈斯治疗公司 2024-06-21 CN disclosed
CN-116916963-A Multivalent ligand clusters with diamine scaffolds for targeted delivery of therapeutic agents 上海舶望制药有限公司 2023-10-20 CN disclosed
CN-114585737-A Oligonucleotide compositions and methods of use thereof 波涛生命科学有限公司 2022-06-03 CN disclosed
CN-109694397-B Cyclic dinucleotide compounds, preparation method and application thereof 上海弘翊生物科技有限公司 2021-08-31 CN disclosed